These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 30909189)

  • 1. Clinical significance of the expression of long non-coding RNA PVT1 in glioma.
    Fang J; Huang J
    Cancer Biomark; 2019; 24(4):509-513. PubMed ID: 30909189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PVT1 polymorphisms in the glioma susceptibility and prognosis.
    Ding X; Zhao Y; Yuan H; Zhang Y; Gao Y
    Eur J Cancer Prev; 2021 Sep; 30(5):400-408. PubMed ID: 33443959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of long non-coding RNA BLACAT1 predicts aggressive clinicopathologic characteristics and poor prognosis of glioma.
    Zhang X; Wei X; Liu J; Yang J; Jin P
    Medicine (Baltimore); 2021 Mar; 100(11):e20722. PubMed ID: 33725920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP4, a new prognostic factor for glioma.
    Wu Q; Yao J
    World J Surg Oncol; 2013 Oct; 11():264. PubMed ID: 24099560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study.
    Liu ZY; Tang F; Wang J; Yang JZ; Chen X; Wang ZF; Li ZQ
    BMC Cancer; 2024 Jun; 24(1):692. PubMed ID: 38844902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of LncRNA PVT1 on clinical characteristics and survival in breast cancer patients: A protocol for systematic review and meta analysis.
    Xie L; Feng G; Zhu P; Xie J
    Medicine (Baltimore); 2021 Feb; 100(8):e24774. PubMed ID: 33663093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of long noncoding RNA PVT1 in various carcinomas: An updated systematic review and meta-analysis.
    Xiao M; Feng Y; Liu C; Zhang Z
    Cell Prolif; 2018 Dec; 51(6):e12519. PubMed ID: 30252166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression level and clinical significance of LncRNA PVT1 in the serum of patients with LEASO.
    Su X; Yuan X; Li F; Yang G; Du L; Zhao F; Zhao R; Ou M
    PeerJ; 2023; 11():e16057. PubMed ID: 37744231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRIT1 could serve as a prognostic biomarker for glioma patients.
    Zhou X; Shao F; Xie Y; Zhang C
    Asian J Surg; 2024 May; 47(5):2247-2249. PubMed ID: 38403546
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal expression of long non‑coding RNA LINC01270 in glioma and its correlation with X‑ray computed tomography signs.
    Liu Y; Zhang Y; E Y; Zhang X; Ma H; Dong F
    Acta Neurobiol Exp (Wars); 2024 Mar; 84(1):43-50. PubMed ID: 38587325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at diagnosis and sex interact to modify primary malignant glioma incidence and survival.
    Schwartzbaum J; Harris R
    Neuro Oncol; 2022 Feb; 24(2):311-312. PubMed ID: 34695207
    [No Abstract]   [Full Text] [Related]  

  • 12. LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related pathway in glioma.
    Chen Y; Ma F; Zhang Z; Guo Y; Shen H; Chen H
    BMC Cancer; 2023 May; 23(1):455. PubMed ID: 37202742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression.
    Li Z; Li M; Xia P; Wang L; Lu Z
    Cancer Biol Ther; 2022 Dec; 23(1):225-233. PubMed ID: 35275031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of REST/NRSF Gene in Glioma and Its ceRNA Network Identification.
    Zhang Y; Wang Q; Wang Z; Zhang C; Xu X; Xu J; Ren H; Shao X; Zhen X; Zhang L; Yu Y
    Front Med (Lausanne); 2021; 8():739624. PubMed ID: 34859007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depleting SOX2 improves ischemic stroke via lncRNA PVT1/microRNA-24-3p/STAT3 axis.
    Chen Z; Fan T; Zhao X; Zhang Z
    Mol Med; 2021 Sep; 27(1):107. PubMed ID: 34521353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review.
    Momtazmanesh S; Rezaei N
    Front Oncol; 2021; 11():712786. PubMed ID: 34322395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8q24.21 Locus: A Paradigm to Link Non-Coding RNAs, Genome Polymorphisms and Cancer.
    Wilson C; Kanhere A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Intergenic Non-Protein Coding RNA 1094 Promotes Initiation and Progression of Glioblastoma by Promoting microRNA-577-Regulated Stabilization of Brain-Derived Neurotrophic Factor.
    Dong X; Fu X; Yu M; Li Z
    Cancer Manag Res; 2020; 12():5619-5631. PubMed ID: 32765065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer.
    Li B; Guo LH; Ban ZQ; Liu L; Luo L; Cui TY
    Medicine (Baltimore); 2020 Jul; 99(28):e21059. PubMed ID: 32664121
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.